Travere Therapeutics Stock Price on October 17, 2024
| TVTX Stock | USD 18.25 0.01 0.05% |
Below is the normalized historical share price chart for Travere Therapeutics extending back to August 13, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Travere Therapeutics stands at 18.25, as last reported on the 24th of November, with the highest price reaching 18.93 and the lowest price hitting 18.03 during the day.
If you're considering investing in Travere Stock, it is important to understand the factors that can impact its price. Travere Therapeutics is not too volatile given 3 months investment horizon. Travere Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.26, which indicates the firm had a 0.26% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.18% are justified by taking the suggested risk. Use Travere Therapeutics Coefficient Of Variation of 360.43, semi deviation of 1.92, and Risk Adjusted Performance of 0.2211 to evaluate company specific risk that cannot be diversified away.
At this time, Travere Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Sale Purchase Of Stock is likely to rise to about 32.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 168 M in 2024. . At this time, Travere Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.1 in 2024, whereas Price Earnings Ratio is likely to drop (6.29) in 2024. Travere Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of November 2012 | 200 Day MA 10.1601 | 50 Day MA 16.6771 | Beta 0.7 |
Travere |
Sharpe Ratio = 0.2618
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TVTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.51 actual daily | 40 60% of assets are more volatile |
Expected Return
| 1.18 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Travere Therapeutics is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Travere Therapeutics by adding it to a well-diversified portfolio.
Price Book 76.1026 | Enterprise Value Ebitda (5.67) | Price Sales 7.8073 | Shares Float 57.9 M | Wall Street Target Price 26.9375 |
Travere Therapeutics Main Headline on 17th of October 2024
CSL Vifor and Travere Therapeutics Announce Swissmedic appro... by finance.yahoo.com
CSL Vifor and Travere Therapeutics, Inc., today announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the treatment of adults with primary IgA nephropathy with a urine protein excretion 1.0 gday .
Travere Therapeutics Valuation on October 17, 2024
It is possible to determine the worth of Travere Therapeutics on a given historical date. On October 17, 2024 Travere was worth 18.05 at the beginning of the trading date compared to the closed value of 18.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Travere Therapeutics stock. Still, in general, we apply an absolute valuation method to find Travere Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Travere Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Travere Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 18.20 | 18.34 | 17.69 | 18.05 | 1,114,898 | |
10/17/2024 | 18.05 | 18.82 | 17.76 | 18.25 | 1,019,584 |
| 18.19 | 18.34 | 17.55 | 17.87 | 858,254 |
| Backtest Travere Therapeutics | | | Travere Therapeutics History | | | Travere Therapeutics Valuation | Previous | Next |
Travere Therapeutics Trading Date Momentum on October 17, 2024
| On October 18 2024 Travere Therapeutics was traded for 17.87 at the closing time. The top price for the day was 18.34 and the lowest listed price was 17.55 . The trading volume for the day was 858.3 K. The trading history from October 18, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.08% . The trading price change against the current closing price is 2.19% . |
Travere Therapeutics Fundamentals Correlations and Trends
By evaluating Travere Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Travere Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Travere financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Travere Therapeutics Stock history
Travere Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Travere is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Travere Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Travere Therapeutics stock prices may prove useful in developing a viable investing in Travere Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74.3 M | 45.7 M | |
| Net Loss | -250.6 M | -238.1 M |
Travere Therapeutics Quarterly Net Working Capital |
|
Travere Therapeutics Stock Technical Analysis
Travere Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Travere Therapeutics Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Travere Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Travere Therapeutics November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Travere Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Travere Therapeutics shares will generate the highest return on investment. By undertsting and applying Travere Therapeutics stock market strength indicators, traders can identify Travere Therapeutics entry and exit signals to maximize returns
Travere Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Travere Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Travere Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Travere to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2211 | |||
| Jensen Alpha | 1.08 | |||
| Total Risk Alpha | 0.5288 | |||
| Sortino Ratio | 0.42 | |||
| Treynor Ratio | 0.9548 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Travere Stock Analysis
When running Travere Therapeutics' price analysis, check to measure Travere Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Travere Therapeutics is operating at the current time. Most of Travere Therapeutics' value examination focuses on studying past and present price action to predict the probability of Travere Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Travere Therapeutics' price. Additionally, you may evaluate how the addition of Travere Therapeutics to your portfolios can decrease your overall portfolio volatility.